Intra-articular injection with triamcinolone hexacetonide in patients with rheumatoid arthritis: prospective assessment of goniometry and joint inflammation parameters

Página do item simplificado
dc.citation.issue2
dc.citation.volume57
dc.contributor.authorVilar Furtado, Rita Nely [UNIFESP]
dc.contributor.authorMachado, Flavia Soares [UNIFESP]
dc.contributor.authorda Luz, Karine Rodrigues [UNIFESP]
dc.contributor.authordos Santos, Marla Francisca [UNIFESP]
dc.contributor.authorKonai, Monique Sayuri [UNIFESP]
dc.contributor.authorLopes, Roberta Vilela [UNIFESP]
dc.contributor.authorNatour, Jamil [UNIFESP]
dc.coverageNew York
dc.date.accessioned2020-07-17T14:02:47Z
dc.date.available2020-07-17T14:02:47Z
dc.date.issued2017
dc.description.abstractObjectives: To evaluate local joint variables after intra-articular injection (IAI) with triamcinolone hexacetonide (HT) in rheumatoid arthritis (RA) patients. Methods: We blindly and prospectively (baseline, 1, 4, 12 and 24 weeks) evaluated metacarpophalangeal (MCP), wrist, elbow, shoulder, knee and ankle joints after HT IAI by the following outcome measures: Visual analogue scale 0-10 cm (VAS) for rest pain (VASR)en
dc.description.abstractVAS for movement pain (VASM)en
dc.description.abstractVAS for joint swelling (VASSw)en
dc.description.abstractflexion (FlexG) and extension (ExtG). Results: 289 patients (635 joints) were studied. VASSw (p < 0,001) and VASR (0,001< p < 0.016) improved from TO to T4, T12 and T24 for all joints. VASM improved from TO-T4 (p < 0.021) for all jointsen
dc.description.abstractTO-T12 (p < 0.023) for MCF and kneeen
dc.description.abstractTO-T24 (p < 0.019) only for MCF and knee. FlexG improved from TO-T4 (p < 0.001) for all jointsen
dc.description.abstractTO-T12 (p < 0.001) and TO-T24 (p < 0.02) only for MCF and knee. ExtG improved from TO-T4 (p < 0.001) for all joints except for elbowen
dc.description.abstractTO-T12 (p = 0.003) for wrist, MCP and kneeen
dc.description.abstractand TO-T24 (p = 0.014) for MCF and knee. Conclusion: VASSw responded better at short and medium term after IAI with HT in our sample of RA patients. (C) 2016 Published by Elsevier Editora Ltda.en
dc.description.affiliationUniv Fed Sao Paulo, Disciplina Reumatol, Sao Paulo, SP, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Disciplina Reumatol, Sao Paulo, SP, Brazil
dc.description.sourceWeb of Science
dc.format.extent115-121
dc.identifierhttp://dx.doi.org/10.1016/j.rbr.2016.06.006
dc.identifier.citationRevista Brasileira De Reumatologia. New York, v. 57, n. 2, p. 115-121, 2017.
dc.identifier.doi10.1016/j.rbr.2016.06.006
dc.identifier.fileWOS000397937700004.pdf
dc.identifier.issn0482-5004
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/55027
dc.identifier.wosWOS:000397937700004
dc.language.isopor
dc.publisherElsevier Science Inc
dc.relation.ispartofRevista Brasileira De Reumatologia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRheumatoid arthritisen
dc.subjectIntra-articular injectionsen
dc.subjectTriamcinoloneen
dc.subjectImprovementen
dc.titleIntra-articular injection with triamcinolone hexacetonide in patients with rheumatoid arthritis: prospective assessment of goniometry and joint inflammation parametersen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
WOS000397937700004.pdf
Tamanho:
280.75 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
Coleções
EPM - Artigos